This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: University of Connecticut. Active years: 2020.
Company Filing History:
Years Active: 2020
Title: Michael N Lombardo: Innovator in Antifolate Compounds
Introduction
Michael N Lombardo is a notable inventor based in Manchester, CT (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds for treating bacterial infections. His innovative work has led to the granting of a patent that showcases his expertise and dedication to advancing medical science.
Latest Patents
Michael N Lombardo holds a patent for "Zwitterionic propargyl-linked antifolates useful for treating bacterial infections." This patent discloses compounds of a specific formula and their pharmaceutically acceptable salts. The patent details methods for inhibiting dihydrofolate reductase (DHFR) both in vitro and in vivo, as well as methods for treating bacterial, fungal, and protozoal infections. The compounds can be utilized as the sole active ingredient in pharmaceutical compositions or combined with other active ingredients.
Career Highlights
Michael N Lombardo is affiliated with the University of Connecticut, where he continues to engage in research and development. His work is characterized by a commitment to finding effective treatments for various infections, showcasing his role as a key player in the pharmaceutical industry.
Collaborations
Some of his notable coworkers include Amy C Anderson and Narendran Gummudipundi Dayanandan. Their collaborative efforts contribute to the innovative research environment at the University of Connecticut.
Conclusion
Michael N Lombardo's contributions to the field of pharmaceuticals, particularly through his patented work on antifolate compounds, highlight his role as an important inventor. His dedication to advancing medical treatments continues to impact the industry positively.